← Back to Search

Thrombectomy Device

JETi Peripheral Thrombectomy Registry (JETi Trial)

N/A
Waitlist Available
Research Sponsored by Walk Vascular LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 days post-index procedure
Awards & highlights
No Placebo-Only Group

Summary

The JETi Registry is a prospective, single-arm, multi-center study to collect real-world data on the safety, performance, and clinical benefits of the JETi™ Hydrodynamic Thrombectomy System (JETi System) for the treatment of acute/subacute thrombosis in the peripheral vasculature. This post-market study will register approximately 280 subjects at approximately 30 centers Globally. Subjects participating in this Registry will be followed through their 12-month follow up visit.

Eligible Conditions
  • Peripheral Artery Thrombosis
  • Deep Vein Thrombosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 days post-index procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 30 days post-index procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
For Arterial Subjects: Clot removal grade for each JETi-treated vessel
For Arterial Subjects: Composite of JETi-related major adverse events (MAEs)
For Venous Subjects: Composite of JETi-related major adverse events (MAEs)
Secondary study objectives
Technical Success

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: JETi™ Hydrodynamic Thrombectomy SystemExperimental Treatment1 Intervention
Subjects who were treated with JETi™ Hydrodynamic Thrombectomy System will be included.

Find a Location

Who is running the clinical trial?

Walk Vascular LLCLead Sponsor
Abbott Medical DevicesLead Sponsor
652 Previous Clinical Trials
416,577 Total Patients Enrolled
1 Trials studying Peripheral Artery Thrombosis
20 Patients Enrolled for Peripheral Artery Thrombosis
~45 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top